Clik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Chlorthalidone Tablets, USP...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
NEOFECT USA to Benefit from Korean IPO Debut
SAN FRANCISCO Korean-American med-tech company NEOFECT today officially began trading on the KOSDAQ, securing more than $17 million in funding. The company, which makes gamified rehabilitation...
View ArticleClik here to view.
Alteogen and Lynkogen Expand Agreement to Include Additional Proprietary...
DAEJEON, South Korea & EAST WINDSOR, N.J. Alteogen Inc. (196170.KQ) and Lynkogen Inc. today announced that they have expanded the scope of their exclusive option agreement. In addition to the...
View ArticleClik here to view.
Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2...
BOTHELL, Wash. & CAMBRIDGE, Mass. & OSAKA, Japan Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) announced that data from the ECHELON-2 phase 3...
View ArticleClik here to view.
AVITA Medical Announces Institutional Placement of A$40.0 Million to Support...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced an institutional placement of A$40.0 million...
View ArticleClik here to view.
ACM Global Laboratories任命Brian Wright为总裁
纽约州罗切斯特和伦敦 (美国商业资讯) — Rochester Regional Health (RRH)是一家22亿美元的综合性医疗保健交付系统，拥有超过17,000名员工，该组织宣布其全资子公司ACM Global Laboratories已聘请Brian Wright来领导ACM Global。 ACM的母公司Rochester Regional Health总裁兼首席执行官Eric...
View ArticleClik here to view.
武田呈报首个评估蛋白酶体抑制剂用于维持治疗的枢纽性3期安慰剂对照试验TOURMALINE-MM3的阳性数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE:4502)今天宣布，3期随机TOURMALINE-MM3研究数据将于2018年12月2日周日在加州圣迭戈召开的美国血液学会(ASH)第60届年会上呈报，该研究评估NINLARO™...
View ArticleClik here to view.
MetLife Expands Access to Genomics to Help Customers in Asia Prevent and...
HONG KONG MetLife continues to expand access to new and differentiated health services for customers in Asia to help them better understand and manage their risk of serious illnesses like cancer and...
View ArticleClik here to view.
Carnot BioSciences, a Spin off of SmartZyme BioPharma, and Hemoshear...
NEW YORK & CHARLOTTESVILLE, Va. SmartZyme BioPharma, an OrbiMed Advisors portfolio company, and Hemoshear Therapeutics today announced a strategic agreement to develop novel protein-based...
View ArticleClik here to view.
ACMグローバル・ラボラトリーズがブライアン・ライトを社長に任命
米ニューヨーク州ロチェスター & ロンドン （ビジネスワイヤ） — 従業員1万7000人以上を擁する22億米ドルの総合医療提供組織のロチェスター・リージョナル・ヘルス（RRH）は、完全子会社のACMグローバル・ラボラトリーズがブライアン・ライトをACMグローバルの統括者に採用したことを発表しました。...
View ArticleClik here to view.
Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition...
OSAKA, Japan NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...
View ArticleClik here to view.
武田薬品、プロテアソーム阻害剤による維持療法を評価する初のピボタル第3相プラセボ対照試験TOURMALINE-MM3の良好データを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
从SmartZyme BioPharma剥离的公司Carnot BioSciences与Hemoshear...
纽约市和弗吉尼亚州夏洛茨维尔 (美国商业资讯) — OrbiMed Advisors成员公司SmartZyme BioPharma与Hemoshear Therapeutics今天宣布一项开发新型蛋白质类治疗药物用于治疗罕见代谢性疾病的战略协议。为支持该合作，SmartZyme将其蛋白质工程平台剥离到一家新公司Carnot...
View ArticleClik here to view.
武田股东批准拟收购Shire plc相关决议
日本大阪 (美国商业资讯)–如在任何司法管辖区内直接或间接发布、出版或分发全部或部分内容构成违反该司法管辖区有关法律的行为，则不得在此等司法管辖区实施该行为。 武田药品工业株式会社(TSE: 4502)（“武田”）今天宣布了其特别股东大会（“EGM”）上关于建议的收购Shire plc（“Shire”）之交易（“收购”）的股东投票结果。...
View ArticleClik here to view.
武田の株主がシャイアー買収案に関連した決議事項を承認
大阪 （ビジネスワイヤ） — 本プレスリリースは、その発表、公表または配布が適用法違反となる法域において、全体または一部を問わず、直接または間接的に発表、公表または配布してはなりません。 武田薬品工業株式会社（東証：4502）（以下「武田」）は本日、シャイアーの買収案（以下「本件買収」）に関する臨時株主総会での株主決議の結果を発表しました。...
View ArticleClik here to view.
Seattle Genetics和武田呈报 ADCETRIS® (Brentuximab...
华盛顿州博瑟尔、马萨诸塞州剑桥和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq:SGEN)和武田药品工业株式会社(TSE:4502)宣布，3期ECHELON-2临床试验数据将于今天在美国血液学会(ASH)第60届年会上进行口述呈报。该数据显示，ADCETRIS (brentuximab...
View ArticleClik here to view.
Aptorum Group Limited Announces Pricing of Initial Public Offering
HONG KONG Aptorum Group Limited (“Aptorum”, or the “Company”), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic...
View ArticleClik here to view.
Visioneering Technologies Inc. Appoints Brian Lane as Chief Financial Officer
ATLANTA Vision care company and manufacturer of the NaturalVue® Multifocal contact lens, Visioneering Technologies (ASX:VTI), is pleased to announce that it has named Brian D. Lane, CPA, as its...
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品がCD30発現末梢性T細胞リンパ腫のフロントライン治療でアドセトリス（ブレンツキシマブ・ベドチン）を検討する第3相ECH...
米ワシントン州ボセル & マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
HEX Innovation Ltd.与菲律宾UPHDMC签署合作协议
香港 (美国商业资讯)–专业从事区块链医疗平台的HEX Innovation Ltd.（首席执行官Sammy Kwok）面向菲律宾卫生部以及菲律宾主要医院举行了宣讲会。HEX在此期间取得的成就包括与UPHDMC (University of Perpetual Help Dalta Medical Center)签署了一项协议。 HEX Innovation首席营销官Alexander...
View Article